These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31280689)

  • 21. Sirolimus use and de novo minimal change nephropathy following renal transplantation.
    Mainra R; Mulay A; Bell R; Karpinski J; Hoar S; Knoll G; Robertson S; Wang D
    Transplantation; 2005 Dec; 80(12):1816. PubMed ID: 16378080
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
    Blasi M; Stadtler H; Chang J; Hemmersbach-Miller M; Wyatt C; Klotman P; Gao F; Wolfe C; Klotman M
    N Engl J Med; 2020 Jan; 382(2):195-197. PubMed ID: 31914248
    [No Abstract]   [Full Text] [Related]  

  • 23. mTOR Inhibition and Cardiovascular Diseases: Cardiac Hypertrophy.
    Paoletti E
    Transplantation; 2018 Feb; 102(2S Suppl 1):S41-S43. PubMed ID: 28230637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In sickness and in health: Living HIV positive kidney donation from a wife to her husband, with 7 years' post-transplant follow-up.
    Grupper A; Goykhman Y; Baruch R; Turner D; Elbirt D; Okrent Smolar L; Katz P; Nachmany I; Lubezky N; Katchman E
    Transpl Infect Dis; 2019 Dec; 21(6):e13171. PubMed ID: 31518477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
    Salazar A; McAlister VC; Kiberd BA; Bitter-Suermann H; Al-Kerithy MF; MacDonald AS
    Transplant Proc; 2001; 33(1-2):1038-9. PubMed ID: 11267181
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
    Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
    Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
    Knapstein J; Galle PR; Zimmermann T
    Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
    [No Abstract]   [Full Text] [Related]  

  • 29. Is sirolimus a nephrotoxic drug? A report of five cases.
    Sabry AA; Elagroudy AE; El-dahshan KF; El-Rahim MA; Sobh MA
    Transplant Proc; 2007 Jun; 39(5):1406-9. PubMed ID: 17580149
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial.
    Paoletti E; Amidone M; Cassottana P; Gherzi M; Marsano L; Cannella G
    Am J Kidney Dis; 2008 Aug; 52(2):324-30. PubMed ID: 18585837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Use-Long-term Follow-up of First Tuberous Sclerosis Complex Patient Treated De Novo With Sirolimus After Kidney Transplantation: A Case Report.
    Tarasewicz A; Dębska-Ślizień A; Rutkowska B; Szurowska E; Matuszewski M
    Transplant Proc; 2018; 50(6):1904-1909. PubMed ID: 30056926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
    Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
    Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents.
    Wilson CC; Wong JT; Girard DD; Merrill DP; Dynan M; An DD; Kalams SA; Johnson RP; Hirsch MS; D'Aquila RT
    J Infect Dis; 1995 Jul; 172(1):88-96. PubMed ID: 7541065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.
    Knoll GA; Kokolo MB; Mallick R; Beck A; Buenaventura CD; Ducharme R; Barsoum R; Bernasconi C; Blydt-Hansen TD; Ekberg H; Felipe CR; Firth J; Gallon L; Gelens M; Glotz D; Gossmann J; Guba M; Morsy AA; Salgo R; Scheuermann EH; Tedesco-Silva H; Vitko S; Watson C; Fergusson DA
    BMJ; 2014 Nov; 349():g6679. PubMed ID: 25422259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.
    Marfo K; Chapochnick-Friedmann J; Akalin E; Lu A
    Transplant Proc; 2009 Dec; 41(10):4411-3. PubMed ID: 20005410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
    Tan CS; Loh HL; Foo MW; Choong LH; Wong KS; Kee TY
    Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
    Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late spontaneous decapsulation of the kidney graft in a patient with hepatitis C and treated with sirolimus: possible pathophysiological association in a rare complication.
    Leal R; Pinto H; Alves R; Figueiredo A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.